In a report published Friday, Morgan Stanley analyst Scott Schmitz assumed coverage on Proto Labs PRLB with an Equal-Weight rating and $70.00 price target.
In the report, Morgan Stanley noted, “Proto Labs has a strong competitive advantage and large TAM, but low visibility and high growth expectations balance the risk:reward. We assume coverage with an Equal-weight rating and establish a $70 price target (31x CY15 EPS of $2.25 or 1.5x PEG).”
Proto Labs closed on Thursday at $68.07.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in